Biallelic <i>BRCA2</i> mutations are associated with multiple malignancies in childhood including familial Wilms tumour

Sarah Reid(Institute of Cancer Research), A Renwick(Institute of Cancer Research), S Seal(Institute of Cancer Research), L Baskcomb(Institute of Cancer Research), R Barfoot(Institute of Cancer Research), H Jayatilake(Institute of Cancer Research), K Pritchard-Jones(Institute of Cancer Research), M R Stratton(Institute of Cancer Research), A Ridolfi-Lüthy(University Children’s Hospital Bern), N Rahman(Institute of Cancer Research)
Journal of Medical Genetics
February 1, 2005
Cited by 122Open Access
Full Text

Abstract

ilms tumour (WT) is an embryonal tumour of the kidney that occurs in 1 in 10 000 children. Familial clusters are rare and account for only 1-3% of cases. ] anconi anaemia (FA, MIM 227650) is a rare autosomal recessive condition affecting ,1 in 300 000 children. FA is characterised by variable congenital abnormalities, short stature, bone marrow failure, hypersensitivity to DNA crosslinking agents, and a predisposition to haematological malignancies such as acute myeloid leukaemia in childhood. A is heterogeneous and consists of at least 11 complementation groups, A, B, C, D1, D2, E, F, G, I, J, and L. 6-8 Eight FA genes have been cloned and at least six FA proteins, FANCA, FANCC, FANCE, FANCF, FANCG, and FANCL, form a nuclear complex required for monoubiquitination of FANCD2. This modification promotes translocation of FANCD2 to DNA repair foci that also contain BRCA1, BRCA2, and RAD51. 9 In 2002, Howlett and colleagues reported biallelic BRCA2 mutations in individuals with Fanconi anaemia D1 (FA-D1). Subsequently, additional FA-D1 and unclassified FA cases were examined and cases with BRCA2 mutations and WT and/or brain tumours were reported.


Related Papers

No related papers found

Powered by citation graph analysis